Safety and Efficacy of Fingolimod in Iranian Patients with Relapsing-remitting Multiple Sclerosis

Safety and Efficacy of Fingolimod in Iranian Patients with Relapsing-remitting Multiple Sclerosis

Introduction: Fingolimod is the first confirmed oral immune-modulator to treat Relapsing-Remitting Multiple Sclerosis (RRMS). This study aimed to investigate the safety and efficacy of fingolimod therapy in Iranian patients with RRMS. Methods: In our trial, 50 patients resistant to conventional inte...

Full description

Bibliographic Details
Main Authors: Fatemeh Yavari, Pardis Oliazadeh, Meisam Radfar, Mohsen Foroughipour, Karim Nikkhah, Alireza Heidari Bakavoli, Morteza Saeidi
Format: Article
Language:English
Published: Iran University of Medical Sciences 2021-03-01
Series:Basic and Clinical Neuroscience
Subjects:
multiple sclerosis
fingolimod
expanded disability status scale (edss)
magnetic resonance imaging (mri)
cardiovascular events
therapy
Online Access:http://bcn.iums.ac.ir/article-1-1412-en.html

Internet

http://bcn.iums.ac.ir/article-1-1412-en.html

Similar Items